Kenny M. Cardenas-Galvez

Medellin, ANT, Colombia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Real World Evidence From 2 Decades of First-Line TKI Therapy in Chronic Myeloid Leukemia (CML): Insights From ACHO's RENEHOC Registry.

Real World Evidence From 2 Decades of First-Line TKI Therapy in Chronic Myeloid Leukemia (CML): Insights From ACHO's RENEHOC Registry.

Journal: Clinical lymphoma, myeloma & leukemia

Published: November 24, 2024

Patients Age 40 Years and Younger With Multiple Myeloma Have the Same Prognosis as Older Patients: An Analysis of Real-World Patients' Evidence From Latin America.

Patients Age 40 Years and Younger With Multiple Myeloma Have the Same Prognosis as Older Patients: An Analysis of Real-World Patients' Evidence From Latin America.

Journal: JCO global oncology

Published: December 07, 2023

Clinical characterization and outcomes of a cohort of colombian patients with AL Amyloidosis.

Clinical characterization and outcomes of a cohort of colombian patients with AL Amyloidosis.

Journal: Colombia medica (Cali, Colombia)

Published: July 04, 2023

JAK2, CALR, and MPL Mutation Profiles in Colombian patients with BCR-ABL Negative Myeloproliferative Neoplasms.

JAK2, CALR, and MPL Mutation Profiles in Colombian patients with BCR-ABL Negative Myeloproliferative Neoplasms.

Journal: Colombia medica (Cali, Colombia)

Published: July 14, 2022

Real-world analysis of treatment patterns and clinical outcomes in patients with newly diagnosed chronic lymphocytic leukemia from seven Latin American countries.

Real-world analysis of treatment patterns and clinical outcomes in patients with newly diagnosed chronic lymphocytic leukemia from seven Latin American countries.

Journal: Hematology (Amsterdam, Netherlands)

Published: October 23, 2020

Different outcomes for transplant-eligible newly diagnosed multiple myeloma patients in Latin America according to the public versus private management: a GELAMM study.

Different outcomes for transplant-eligible newly diagnosed multiple myeloma patients in Latin America according to the public versus private management: a GELAMM study.

Journal: Leukemia & lymphoma

Published: August 27, 2020

Uvula Amyloidosis.

Uvula Amyloidosis.

Journal: The New England journal of medicine

Published: August 07, 2020

Chylothorax as an Initial Manifestation of Waldenström macroglobulinemia.

Chylothorax as an Initial Manifestation of Waldenström macroglobulinemia.

Journal: Cureus

Published: May 09, 2020

Mast cell activation syndrome. About a clinical case

Mast cell activation syndrome. About a clinical case

Journal: Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993)

Published: February 28, 2020

Treatment of post-transplantation lymphoproliferative disorders after kidney transplant with rituximab and conversion to m-TOR inhibitor.

Treatment of post-transplantation lymphoproliferative disorders after kidney transplant with rituximab and conversion to m-TOR inhibitor.

Journal: Colombia medica (Cali, Colombia)

Published: March 16, 2017

Hemolytic uremic syndrome due to gemcitabine in a young woman with cholangiocarcinoma.

Hemolytic uremic syndrome due to gemcitabine in a young woman with cholangiocarcinoma.

Journal: Jornal brasileiro de nefrologia

Published: June 08, 2015

Showing 1-11 of 11

Last Updated: 09/26/2026